Results 21 to 30 of about 2,458,624 (375)

Trajectories of medication for opioid use disorder and their impact on HIV testing among people who inject drugs in India: A longitudinal assessment of clinic-based data. [PDF]

Addiction
Abstract Aims The aim of this study was to identify longitudinal trajectories of medication for opioid use disorder (MOUD) use throughout 1 year following MOUD initiation and to examine the association of trajectory membership with HIV testing among people who inject drugs in India.
McFall AM, Ganapathi L, Gunaratne MP, Srikrishnan AK, Vasudevan CK, Anand S, Solomon SS, Mehta SH, Lucas GM.   +8 more
europepmc   +2 more sources

Medications for management of opioid use disorder

American Journal of Health-System Pharmacy, 2019
Abstract Purpose The use of buprenorphine, methadone, and long-acting naltrexone for treatment of opioid use disorder (OUD) is discussed, including a review of current literature detailing treatment approaches and action steps to optimize treatment in acute care and office-based settings.
Patrick J. Bridgeman, Jennifer L. Koehl, David E. Zimmerman   +2 more
openaire   +3 more sources

Medication for opioid use disorder at hospital discharge is not associated with intravenous antibiotic completion in post-acute care facilities

Therapeutic Advances in Infectious Disease, 2022
Background: People with opioid use disorder and severe infections may complete their prolonged courses of outpatient parenteral antimicrobial therapy at a post-acute care facility due to adherence and safety concerns.
Edward C. Traver, Patrick R. Ching, Shivakumar Narayanan   +2 more
doaj   +1 more source

Use of a Decision Aid in Medication Initiation Among Patients with Opioid Use Disorder and HIV [PDF]

, 2023
Opioid use disorder refers to the maladaptive use of prescribed or illicit opioids. This condition can be treated using pharmacotherapy referred to as medications for opioid use disorder (MOUD), but they are underutilized.
Gateley, Katrina
core   +1 more source

Sorting through life: evaluating patient-important measures of success in a medication for opioid use disorder (MOUD) treatment program

Substance Abuse Treatment, Prevention, and Policy, 2023
Background Medication for opioid use disorder (MOUD) is the gold standard treatment for opioid use disorder. Traditionally, “success” in MOUD treatment is measured in terms of program retention, adherence to MOUD, and abstinence from opioid and other ...
Megan K. Reed, Kelsey R. Smith, Francesca Ciocco, Richard W. Hass, Avery Lin Cox, Erin L. Kelly, Lara C. Weinstein   +6 more
doaj   +1 more source

Addressing opioid use disorder among rural pregnant and postpartum women: a study protocol

Addiction Science & Clinical Practice, 2020
Background Opioid use disorder (OUD) among women delivering at a hospital has increased 400% from 1999–2014 in the United States. From the years 2007 to 2016, opioid-related mortality during pregnancy increased over 200%, and drug-overdose deaths made up
M. Aryana Bryan, Marcela C. Smid, Melissa Cheng, Katherine T. Fortenberry, Amy Kenney, Bhanu Muniyappa, Danielle Pendergrass, Adam J. Gordon, Gerald Cochran   +8 more
doaj   +1 more source

The Substance Use Treatment and Recovery Team (START) study: protocol for a multi-site randomized controlled trial evaluating an intervention to improve initiation of medication and linkage to post-discharge care for hospitalized patients with opioid use disorder

Addiction Science & Clinical Practice, 2022
Background People with opioid use disorder experience high burden of disease from medical comorbidities and are increasingly hospitalized with medical complications.
Allison J. Ober, Cristina Murray-Krezan, Kimberly Page, Peter D. Friedmann, Karen Chan Osilla, Stephen Ryzewicz, Sergio Huerta, Mia W. Mazer, Isabel Leamon, Gabrielle Messineo, Katherine E. Watkins, Teryl Nuckols, Itai Danovitch   +12 more
doaj   +1 more source

Recovery capital among people receiving treatment for opioid use disorder with buprenorphine

Harm Reduction Journal, 2021
Background Recovery is a multidimensional process that includes health, quality of life, and citizenship. Recovery capital is a strengths-based concept representing the sum of an individual’s resources that support recovery.
Anna Beth Parlier-Ahmad, Mishka Terplan, Dace S. Svikis, Laura Ellis, Caitlin E. Martin   +4 more
doaj   +1 more source

Hospitalist perspectives on buprenorphine treatment for inpatients with opioid use disorder

Drug and Alcohol Dependence Reports, 2022
Background: Patients with opioid use disorder (OUD) have high hospital admission rates. Hospitalists, clinicians that work in inpatient medical settings, may have a unique opportunity to intervene on behalf of these patients, yet their experience with ...
Megan K Reed, Vignesh Murali, Nazanin Sarpoulaki, Jillian H. Zavodnick, Jeffrey K. Hom, Kristin L Rising   +5 more
doaj  

Medicaid expansion and treatment for opioid use disorders in Oregon: an interrupted time-series analysis

Addiction Science & Clinical Practice, 2019
Background The study examined the association of the Affordable Care Act’s 2014 Medicaid expansion on the use of psychosocial services and pharmacotherapies for opioid use disorders among Oregon Medicaid recipients.
Dennis McCarty, Yifan Gu, John W. McIlveen, Bonnie K. Lind   +3 more
doaj   +1 more source